Cancer Genetics, AstraZeneca Announce Biomarker and MDx Partnership

News   Jun 10, 2014

 
Cancer Genetics, AstraZeneca Announce Biomarker and MDx Partnership
 
 
 

RELATED ARTICLES

Combination Chemotherapy Could Significantly Improve Deadly Brain Tumor Treatment

News

A team led by Massachusetts General Hospital (MGH) investigators has found that adding the chemotherapy drug hydroxyurea to the current chemotherapy protocol for glioblastoma significantly increased survival in animal models.

READ MORE

Multifunctional Vehicle Transports CRISPR-Cas9 system to Tumor Cell Genome

News

Researchers report their nonviral transport and release platform of gene-editing systems has the additional advantage of combining hyperthermal cancer therapy with genetic modification.

READ MORE

Barrier to Liquid Biopsies Overcome with Blood Stabilization Technique

News

A new technique that prolongs the lifespan of blood samples could be a breakthrough for liquid biopsy assays.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE